$7.4 B

BIO Mkt cap, 14-Dec-2018

$545.1 M

Bio-Rad Revenue Q3, 2018
Bio-Rad Gross profit (Q3, 2018)286.7 M
Bio-Rad Gross profit margin (Q3, 2018), %52.6%
Bio-Rad Cash, 30-Sep-2018434.5 M

Bio-Rad Revenue Breakdown

Embed Graph

Bio-Rad revenue breakdown by business segment: 36.3% from Life Science, 63.0% from Clinical Diagnostics and 0.7% from Other

Bio-Rad revenue breakdown by geographic segment: 6.5% from Other (primarily Canada and Latin America), 37.0% from United States, 21.4% from Pacific Rim and 35.1% from Europe

Bio-Rad Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

2.1b2.2b2.0b2.1b2.2b

Revenue growth, %

2%(7%)2%4%

Cost of goods sold

897.8m930.1m972.8m

Gross profit

1.1b1.1b1.2b

Gross profit Margin, %

56%55%55%

R&D expense

205.9m250.3m

General and administrative expense

816.7m808.9m

Operating expense total

1.0b1.1b

EBIT

166.7m53.2m116.7m

EBIT margin, %

8%3%5%

Interest expense

21.7m21.9m21.9m

Pre tax profit

145.8m41.6m97.8m

Income tax expense

(32.8m)(15.6m)24.4m

Net Income

77.8m88.8m113.1m26.0m122.2m

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

505.1m509.3m536.8m530.6m472.8m506.1m470.0m471.2m516.8m508.7m500.1m504.7m535.0m551.5m1.1b545.1m

Cost of goods sold

220.9m234.1m239.6m242.1m202.7m226.5m206.5m207.2m236.5m229.3m230.1m231.4m230.5m249.3m523.6m258.4m

Gross profit

284.2m275.3m297.2m288.6m270.1m279.6m263.5m264.0m280.2m279.5m270.0m273.3m304.5m302.2m603.9m286.7m

Gross profit Margin, %

56%54%55%54%57%55%56%56%54%55%54%54%57%55%54%53%

R&D expense

61.4m49.4m96.9m49.2m

General and administrative expense

196.8m209.1m419.6m201.2m

Operating expense total

258.1m258.6m516.4m250.4m

Interest expense

31.6m3.9m5.6m7.7m5.0m4.8m5.8m5.6m5.6m5.6m5.0m5.8m5.6m5.8m11.8m6.1m

Pre tax profit

(5.2m)14.5m48.8m22.5m26.7m39.5m25.4m20.2m26.9m22.7m20.1m1.1m38.9m863.7m1.2b350.1m

Income tax expense

(1.9m)(7.9m)(17.2m)(11.0m)(8.9m)(11.1m)(8.0m)(7.9m)(8.8m)(4.3m)(7.7m)3.9m(11.5m)(206.9m)(279.0m)(80.8m)

Net Income

(7.1m)6.7m31.6m11.5m17.8m28.4m17.4m12.3m30.3m48.7m12.4m17.4m

Bio-Rad Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

331.6m413.3m457.5m456.3m383.8m

Accounts Receivable

372.3m464.8m

Prepaid Expenses

91.0m146.1m

Inventories

525.0m594.8m

Current Assets

1.7b1.7b1.8b1.8b2.0b

PP&E

429.4m428.8m437.7m1.2b1.3b

Goodwill

477.1m506.1m

Total Assets

3.4b3.3b3.7b3.9b4.3b

Accounts Payable

148.5m128.6m122.4m133.1m135.2m

Short-term debt

334.0k420.0k

Current Liabilities

487.5m446.8m441.4m471.3m502.7m

Long-term debt

434.2m434.6m

Total Debt

434.5m435.0m

Total Liabilities

1.3b1.3b

Common Stock

2.0k2.0k2.0k2.0k2.0k

Preferred Stock

Additional Paid-in Capital

240.0m271.3m300.4m332.9m361.2m

Retained Earnings

1.6b1.7b1.8b1.8b1.8b

Total Equity

2.2b2.2b2.5b2.6b2.9b

Debt to Equity Ratio

0.2 x0.1 x

Debt to Assets Ratio

0.1 x0.1 x

Financial Leverage

1.5 x1.5 x1.5 x1.5 x1.5 x

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

291.8m364.5m384.7m424.6m425.7m450.1m507.3m403.6m418.7m417.9m291.7m321.6m328.9m407.3m403.0m434.5m

Accounts Receivable

383.5m383.9m378.9m354.4m342.2m354.2m341.5m381.1m366.3m367.7m373.4m392.8m419.7m430.4m404.1m381.5m

Inventories

523.5m513.9m520.6m516.0m478.4m501.0m512.7m533.3m541.5m556.4m559.8m580.6m601.6m612.2m591.4m601.1m

Current Assets

1.7b1.8b1.8b1.8b1.7b1.7b1.8b1.8b1.8b1.9b1.7b1.8b1.9b2.0b2.0b2.0b

PP&E

425.1m430.9m440.3m420.9m428.3m439.6m433.8m449.2m457.7m474.7m505.1m503.3m500.7m499.7m490.2m484.3m

Total Assets

3.3b3.4b3.5b3.4b3.3b3.5b3.7b3.8b3.9b4.0b4.0b4.1b4.2b6.2b6.4b6.7b

Accounts Payable

131.9m130.9m125.5m126.6m

Current Liabilities

462.9m481.3m480.2m503.8m416.9m403.9m435.2m400.9m410.4m442.7m407.5m455.1m466.5m456.2m442.4m453.2m

Total Liabilities

1.2b1.2b1.2b1.2b1.1b1.2b1.2b1.2b1.3b1.3b1.2b1.3b1.3b1.7b1.7b1.8b

Common Stock

2.0k2.0k2.0k2.0k2.0k2.0k2.0k2.0k2.0k2.0k2.0k2.0k2.0k2.0k2.0k2.0k

Additional Paid-in Capital

232.0m247.3m254.3m259.9m278.4m285.7m291.9m308.9m316.8m324.6m342.6m347.7m350.7m371.0m376.6m382.4m

Retained Earnings

1.6b1.6b1.6b1.7b1.7b1.7b1.8b1.8b1.8b1.9b1.8b1.9b1.9b4.0b4.3b4.6b

Total Equity

2.1b2.2b2.2b2.2b2.2b2.4b2.4b2.5b2.6b2.7b2.7b2.8b2.8b4.5b4.6b4.9b

Financial Leverage

1.5 x1.5 x1.5 x1.6 x1.5 x1.5 x1.5 x1.5 x1.5 x1.5 x1.5 x1.5 x1.5 x1.4 x1.4 x1.4 x

Bio-Rad Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

77.8m88.8m113.1m

Accounts Receivable

Inventories

Accounts Payable

Cash From Operating Activities

175.5m273.3m186.2m216.4m103.9m

Cash From Investing Activities

(5.4m)(190.5m)(166.9m)(213.9m)(175.6m)

Cash From Financing Activities

(311.7m)11.7m8.6m9.0m341.0k

Net Change in Cash

(1.3m)(72.4m)

Interest Paid

(61.2m)(20.8m)(20.8m)(21.3m)(21.1m)

Free Cash Flow

62.5m152.3m74.2m75.0m(7.4m)

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Net Income

31.6m11.5m17.8m28.4m17.4m12.3m30.3m48.7m12.4m17.4m44.8m

Depreciation and Amortization

105.2m36.7m70.7m106.1m

Accounts Receivable

14.8m39.6m378.9m354.4m342.2m354.2m341.5m381.1m366.3m367.7m373.4m(1.8m)(22.4m)

Inventories

(57.2m)(11.4m)(37.9m)(56.2m)

Accounts Payable

125.5m126.6m

Cash From Operating Activities

102.0m68.9m6.2m34.5m40.3m118.2m180.5m

Cash From Investing Activities

36.9m(38.9m)(147.7m)(162.5m)(18.8m)(102.7m)(132.2m)

Cash From Financing Activities

(315.5m)3.5m(395.0k)(3.2m)2.5m499.0k(1.7m)

Interest Paid

(50.2m)(292.0k)

Free Cash Flow

18.7m43.0m(58.8m)(50.7m)13.2m64.3m104.5m

Bio-Rad Ratios

USDY, 2018

Financial Leverage

1.4 x
Report incorrect company information

Bio-Rad Employee Rating

3.0553 votes
Culture & Values
3.1
Work/Life Balance
3.4
Senior Management
2.7
Salary & Benefits
3.3
Career Opportunities
2.8
Source